Mortality and morbidity data continue to indicate there is a compellin
g need for the derivation of a new generation of vaccine delivery syst
ems that can be usefully applied via injection and also mucosally One
technology that has potential for design as an effective vaccine deliv
ery system is the formulation of biodegradable microparticles from the
polymers and poly lactide co-glycolide (PLGA) in particular. The pote
ntial advantages of the delivery of vaccines within such microparticle
s is discussed. The potential for eliciting and optimising immunity af
ter the mucosal delivery of biodegradable microparticles is also discu
ssed.